Supplementary Figure from A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors

Niharika B. Mettu,Susanna V. Ulahannan,Johanna C. Bendell,Ignacio Garrido-Laguna,John H. Strickler,Kathleen N. Moore,Robert Stagg,Ann M. Kapoun,Leonardo Faoro,Sunil Sharma

crossref（2023）

引用 0|浏览11

暂无评分

摘要

Supplementary Figure from A Phase 1a/b Open-Label, Dose-Escalation Study of Etigilimab Alone or in Combination with Nivolumab in Patients with Locally Advanced or Metastatic Solid Tumors

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要